Condition

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer clinical trials and research

• 2Clinical trials
• 6Countries

All recruiting trials (2)

• HLX43 alone or with HLX07 vs docetaxel in advanced or metastatic squamous NSCLC

  This study tests HLX43 by itself or with HLX07 to see if it helps people whose squamous NSCLC has come back or spread after platinum-based chemotherapy and anti-PD-1/PD-L1 therapy, compared with docetaxel.

  Recruiting Phase 2/3 Shanghai Henlius Biotech · Beijing, Beijing Municipality · NCT07459751

• Testing a new antibody treatment for advanced squamous cell cancers

  This study is testing a new antibody treatment combined with chemotherapy for people with advanced squamous cell cancers that haven't responded to standard therapies.

  Recruiting at 17 sites Phase 1/2 Hummingbird Bioscience · Sydney, New South Wales and 19 other locations · NCT05910827

Related topics

Quick answers

How many Advanced or Metastatic Squamous Non-Small Cell Lung Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (1 trial), Australia (1 trial), Moldova (1 trial), Singapore (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →